RecruitingPhase 3NCT07356284

Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis


Sponsor

ProMedica Health System

Enrollment

342 participants

Start Date

May 19, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The study objective is to establish the safety and efficacy of endovascular adjunct stenting for patients undergoing mechanical thrombectomy (MT) that are found to have residual stenosis (70-99%) following attempted clot retrieval with either aspiration catheters or stent retrievers, per device instructions for use and device labeling.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Mechanical Thrombectomy and a procedure called Mechanical Thrombectomy plus adjunct stenting for people with acute ischemic stroke, brain stroke, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREMechanical Thrombectomy plus adjunct stenting

Mechanical thrombectomy and adjunct stentiing

DEVICEMechanical Thrombectomy

Mechanical thrombectomy only


Locations(1)

ProMedica Toledo Hospital

Toledo, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07356284


Related Trials